Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Hutchmed
Grupo Espanol de Tumores Neuroendocrinos
Advanced Accelerator Applications
Grupo Espanol de Tumores Neuroendocrinos
SCRI Development Innovations, LLC
Hoffmann-La Roche
Pfizer
University of California, San Francisco
Yale University
Columbia University
Merck Sharp & Dohme LLC
Novartis